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Case Report
Follicular Dendritic Cell Sarcoma of Lymph Node - a Rare Entity
Safoorah Khalid, Nausheen Yaqoob, Shahid Pervez
Department of Pathology and Microbiology, The Aga Khan University, Karachi.

Abstract
Follicular dendritic cells (FDC) are non-lymphoid,
non-phagocytic accessory cells in the immune system that
are essential for antigen presentation and germinal center
reaction regulation1. These cells are CD21+, CD35+, CD1aand S100 protein + and they show desmosomes ultrastructurally.
The most commonly involved sites by FDC tumors
are lymph nodes but may arise at a variety of extranodal
sites including oral cavity, tonsil, gastrointestinal tract and
liver. Most studies represent single case reports or case
series.
Our patient presented with tumor in the lymph
nodes. Histology revealed tumor cells with abundant
eosinophilic cytoplasm, hyperchromatic and pleomorphic
nuclei, and prominent nucleoli. The tumor cells were found
to be positive for CD21 which is a specific marker for follicular dendritic cells.

Introduction
Follicular dendritic cells (FDC) are non-lymphoid,
non-phagocytic accessory cells in the immune system that
are essential for antigen presentation and germinal center
reaction regulation.1 They form tight meshworks within
lymphoid follicles. These cells are CD21+, CD35+, CD1aand S100 protein + and they show desmosomes ultrastructurally.
Neoplasms showing FDC differentiation were first
recognized by Monda et al in 1986.2 The most commonly
involved sites are lymph nodes but may arise at a variety of
extranodal sites including oral cavity, tonsil, gastrointestinal
tract and liver. Most studies represent single case reports or
case series. The apparent rarity may be explained in part by
under-recognition of the entity.3
Histologically FDC tumor is composed of spindle to
ovoid cells that are arranged in fasicles, storiform patterns
and whorls. The individual neoplastic cells generally have
plump, slightly eosinophilic cytoplasm with indistinct cell
borders. The nuclei are elongated, with vesicular or granular finely dispersed chromatin, small but distinct nucleoli,
and a delicate nuclear membrane. Lymphocytes are characteristically sprinkled throughout the tumor. Nonetheless, the
recognized morphologic spectrum of FDC sarcoma has
broadened over the years, such as endocrine tumor like vasculature, polygonal cells, hyaline cytoplasm, and myxoid
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stroma; and a definitve diagnosis always requires confirmation by immunohistochemical and/ or ultrastructural studies.4
We report a case of follicular dendritic cell sarcoma
of the lymph node.

Case Report
We describe a 46 year old male having cervical lymphadenopathy since two months. There was no history of
generalized lymphadenopathy. General physical and systemic examination was unremarkable. No visceromegaly
was present. Haematological examination revealed
Haemoglobin 13.8gm/dl, Haematocrit 40%, TLC 6x109/L
and Platelets 320x109/L. Excisional biopsy of the lymph
node was done which showed effacement of the nodal architecture by a neoplastic lesion exhibiting sheets of large
tumor cells with moderate amount of cytoplasm. Spindly
appearance of the tumor cells was also noted. The nuclei
showed moderate to severe pleomorphism and hyperchromasia (Figure 1). Occasional prominent nucleoli were seen.
Abundant mitotic figures were present. No glycogen positivity was seen on special stains. Initial panel of immunohistochemistry was negative for epithelial markers (cytokeratin
MNF, CK Cam 5.2, EMA) and Lymphoid panel (LCA, Pan
B markers; CD 20 and CD 79a, Ki-1, CD 30, ALK protein)
and S-100, CD 68, CD31, CD34, HMB45, Vimentin,
ASMA and Desmin. The only positive mother was CD 21
(Figure 2). The case was diagnosed as Follicular dendritic
cell sarcoma/tumor according to WHO/REAL classification
system.

Figure 1:H & E Sections showing effaced nodal architecture by large tumor cells with moderate
cytoplasm and pleomorphic nuclei. (Mag 20x)
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phoma, Langerhan's cell histiocytosis, spindle cell carcinoma and a variety of other mesenchymal lesions. The diagnosis should be confirmed with the use of immunohistochemistry, especially in extranodal organs.
Little is known about the etiology of FDC sarcoma.
There is an association of FDC sarcoma with Castleman disease of hyaline-vascular type.4,9 The tumor has been found
to be associated with EBV in cases occurring predominantly in liver and spleen7,10 usually in cases with an inflammatory pseudotumour like appearance.
In conclusion, FDC sarcoma is a rare entity and
awareness of this tumor requires an alert mind, especially if
a preliminary panel of immunostains fails to reveal cytokeratin expression.
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FDC is a low grade malignant neoplasm and distant
metastases have been described3. The local recurrence rate
is 40% and metastatic rate is 25%.8 When FDC sarcoma
metastasizes, the lung is a predilection site in addition to
lymph node and liver.3
Our patient presented with tumor in the lymph nodes.
Histology revealed tumor cells with abundant eosinophilic
cytoplasm, hyperchromatic, pleomorphic and prominent
nucleoli. The tumor cells were found to be positive for CD21
which is a specific marker for follicular dendritic cells.
The differential diagnosis depends, in part, on the
tumor location and may include thymoma, large cell lymphoma, peripheral nerve sheath tumor, histiocytic lym-
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